Other potentially deleterious variants of STOX1 have been identified in a whole-exome sequencing study carried out in Colombian patients affected by the HELLP (hemolysis, elevated liver enzyme, low platelet) syndrome, a severe multi-organ complication of preeclampsia. Here, STOX1 is linked to preeclampsia.